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Glomerular ﬁltration rate (eGFR) by serum creatinine (eGFRCr) or
standardized cystatin C (eGFRCysC) were estimated in Japanese
patients with Graves' disease (GD) of different sex. Clinical samples
were collected from patients with GD with normal renal function to
accurately validate eGFRCr and eGFRCysC levels and evaluate how
hyperthyroidism affects renal function. Levels of eGFRCr and eGFRCysC
showed clinical usefulness in successfully treated euthyroid patients
with GD regardless of sex. The article includes detailed experimental
methods and data used in our analysis. The data relates to the
“Paradoxical effect of thyroid function on the estimated glomerular
ﬁltration rate by serum creatinine or standardized cystatin C in
Japanese Graves’ disease patients” (Suzuki et al., 2015) [1]
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ata accessibility All publicly released data are within this articleDValue of the data The data included important resources for clinician and researchers regarding changes in estimated
glomerular ﬁltration rate (eGFR) levels when evaluating renal function in patients with Graves'
disease (GD) in the ﬁeld of clinical medicine.
 The article provides analysis data of two different eGFR equations depending to sex.
 Tha data showing effect of treatment in patients with GD is useful for other researchers and
clinicians.1. Experimental design and data
GD is an autoimmune disease that affects thyroid function. It frequently results in hyperthyroidism
and an enlarged thyroid gland. Typically, increased free triiodothyronine (FT3), free thyroxine (FT4),
and thyroid stimulating hormone (TSH) antibodies and decreased TSH are noted in clinical exam-
ination. GD occurs in approximately 0.5% of patients [2] and is approximately 7.5 times more frequent
in women than men [2]. We collected 113 outpatients with untreated or poorly controlled GD. Control
subjects included 146 healthy volunteers without physical or clinical abnormalities upon routine
health check. Clinical characteristics of clinical samples from males and females have been described
in a related report [1]. The patients with GD were categorized into two groups (remission or non-
remission), following pharmacotherapy indicated by the Japan Thyroid Association guidelines
(methimazole and/or propylthiouracil). Diagnostic criteria were based on the changes in TSH, FT3, and
FT4 levels following treatment [1]. Clinical characteristics have been described in the accompanying
report before and after treatment during the medication period (8.272.8 months) in the remission
and non-remission groups [1]. The changes in TSH, FT3, and FT4 levels, before and after treatment, in
the remission and non-remission groups are listed in Supplemental Fig. 1. Remission group returned
to reference interval (TSH: o0.003 to 2.0270.85, FT3: 14.4710.1 to 4.270.7, FT4: 29.0712.2 to
11.772.3) and non-remission group did not returned to reference interval (TSH: o0.003 to 0.016,
FT3: 18.9712.2 to 8.575.5, FT4: 32.5711.3 to 21.077.5). Correlations between eGFR calculated by
serum creatinine (sCr) levels (eGFRCr) and elevated FT3 and FT4 levels in males or females with GD
are shown in Supplemental Fig. 2. eGFRCr levels of males (bias: 2.42, 1.81) and females (bias: 2.14,
1.86) are increasing with elevated FT3 and FT4 levels. Correlations between eGFR calculated by
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females with GD are shown in Supplemental Fig. 3. eGFRCysC levels of males (bias: −0.86, −0.72) and
females (bias: −0.88, −0.72) are decreasing with elevated FT3 and FT4 levels. Validation of the effect
on levels of eGFRCr and eGFRCysC, before and after treatment, in remission and non-remission groups
are shown in Supplemental Fig. 4. Levels of eGFRCr and eGFRCysC after treatment in remission group
showed same tendency (102.877.4 and 105.678.7), but levels of eGFRCr and eGFRCysC before
treatment in remission, before and after in non-remission groups showed different tendency
(138.7725.3 and 75.9712.9, 136.2733.6 and 74.8719.1, 120.2727.7 and 85.4719.6).2. Materials and methods
2.1. Preparation of biological samples
Blood samples were obtained using vacuum blood collection tubes with coated glass powder to
prevent blood coagulation (Kyokuto Seiyaku, Tokyo, Japan) in the blood-drawing room at Chiba
university hospital. After coagulation, blood samples were centrifuged (Hitachi, Tokyo, Japan) at
3000 g for 7 min, and hemocytic components and serum were separated. Serum samples were stored
at 80 °C until further use. Written informed consent was obtained from all patients and healthy
control subjects before blood sampling. Our study protocol was approved by the ethics committee of
Chiba University Graduate School of Medicine.
2.2. Data analysis
The based data used in this study were obtained as follows: sCr levels were measured using an
enzymatic method (CRE LM; Wako, Osaka, Japan), with a reference interval of 54–92 μmol/L and 42–
70 μmol/L for males and females, respectively, and a coefﬁcient of variation (CV) of 1.0%. The proce-
dure for measuring sCysC was standardized based on international reference material published in
2010 [3]. Standardized sCysC levels were measured using latex turbidimetric immunoassay (N-assay
LA cystatin C; Nittobo, Tokyo, Japan), with a reference interval of 0.60–0.98 mg/L and 0.49–0.82 mg/L
for males and females, respectively, and a 0.9% CV. Standardized sCysC and sCr were measured using a
BioMajesty 8040 analyzer (JEOL, Tokyo, Japan) according to the manufacturer's instructions. Serum
TSH, FT3, and FT4 levels were measured by chemiluminescent immunoassay using an ARCHITECT
i2000SR analyzer (Abotto Japan, Tokyo, Japan) according to the manufacturer's instructions. Reference
intervals were as follows: TSH, 0.35–4.94 mIU/L (CV¼1.6%); FT3, 2.6–5.7 pmol/L (CV¼9.8%); and FT4,
9.0–19.1 pmol/L (CV¼9.9%).
2.3. Calculation of eGFR
In this report, renal function was evaluated using eGFRCr and eGFRCysC, which were calculated
using equations reported by the Japanese Society of Nephrology as follows [3,4]:
eGFRCr¼194 (sCr0.011312)1.094 (Age)0.287 (0.739 if female)
eGFRCysC¼(104 (standardized sCysC)1.019Age0.996 (0.929 if female))8
eGFRCr and eGFRCysC are expressed as mL/min/1.73 m2 of body surface area. sCr is expressed as mg/
dL (if μmol/L/88.6), and standardized sCysC is expressed as mg/L [3,4].
2.4. Statistical analysis
Summary statistics were constructed using frequencies and proportions for categorical data and
means and standard deviations (SD) for continuous variables. Student's t-test was used to compare
groups in all experiments. All comparisons were planned, and statistical tests were two-sided. All
statistical analyses were performed using StatFlex version 5.0 (ArTeC Inc., Osaka, Japan). Mean and SD
were used for descriptive statistics. p valueso0.05 were considered statistically signiﬁcant.
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Supplementary data associated with this article can be found in the online version at http://dx.doi.
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